Evidence map›Paper›PMID 11481491›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Gene program for cardiac cell survival induced by transient ischemia in conscious pigs.

C Depre, J E Tomlinson, R K Kudej, V Gaussin, E Thompson, S J Kim, D E Vatner, J N Topper, S F Vatner

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Reply: Apoptosis, A Double-Edge Sword!JACC. Basic to translational science · 2017
    Article
  10. Article
  11. Multifunctional protein: cardiac ankyrin repeat protein.Journal of Zhejiang University. Science. B · 2016
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

C DepreCardiovascular Research Institute, Department of Medicine, University of Medicine and Dentistry New Jersey, New Jersey Medical School, Newark, NJ 07103, USA. cdepre@humed.com
J E Tomlinson
R K Kudej
V Gaussin
E Thompson
S J Kim
D E Vatner
J N Topper
S F Vatner
Hackensack University Medical Center · USVIR Biotechnology (United States) · US

Funding

Molecular Mechanisms in Chronically Stunned MyocardiumP01HL069020 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2001 to 2014
$21.3M
SARCOMERIC PROTEIN MUTATIONS IN HYPERTROPHY AND HEART FAILUREP01HL059139 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI RYDEN, EVA B · 1997 to 2007
$12.4M
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATESR01HL033107 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1985 to 2011
$6.2M
AGING EFFECTS ON CARDIOVASCULAR FUNCTION IN PRIMATESR01AG014121 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1996 to 2007
$3.5M
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATESR37HL033107 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1992 to 2001
$1.2M
TRANSMURAL SR REGULATION IN LV HYPERTROPHYR01HL065182 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY E · 1999 to 2003
$1.0M
BETA-ADRENERGIC SIGNALING, DENERVATION AND HEART FAILURER01HL065183 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY E · 1999 to 2002
$759k
MYOCARDIAL ISCHEMIA AND CORONARY ARTERY REPERFUSIONR01HL033065 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1985 to 2000
$376k
NHLBI NIH HHS HL33065NHLBI NIH HHS HL 33107NHLBI NIH HHS HL65182NHLBI NIH HHS HL65183NHLBI NIH HHS HL69020NHLBI NIH HHS P01 HL059139NHLBI NIH HHS P01 HL069020NHLBI NIH HHS P01 HL 59139NHLBI NIH HHS R01 HL033107NHLBI NIH HHS R01 HL065182NHLBI NIH HHS R37 HL033107NIA NIH HHS AG 14121NIA NIH HHS R01 AG014121
6 · The paper itself

Abstract

Therapy for ischemic heart disease has been directed traditionally at limiting cell necrosis. We determined by genome profiling whether ischemic myocardium can trigger a genetic program promoting cardiac cell survival, which would be a novel and potentially equally important mechanism of salvage. Although cardiac genomics is usually performed in rodents, we used a swine model of ischemia/reperfusion followed by ventricular dysfunction (stunning), which more closely resembles clinical conditions. Gene expression profiles were compared by subtractive hybridization between ischemic and normal tissue of the same hearts. About one-third (23/74) of the nuclear-encoded genes that were up-regulated in ischemic myocardium participate in survival mechanisms (inhibition of apoptosis, cytoprotection, cell growth, and stimulation of translation). The specificity of this response was confirmed by Northern blot and quantitative PCR. Unexpectedly, this program also included genes not previously described in cardiomyocytes. Up-regulation of survival genes was more profound in subendocardium over subepicardium, reflecting that this response in stunned myocardium was proportional to the severity of the ischemic insult. Thus, in a swine model that recapitulates human heart disease, nonlethal ischemia activates a genomic program of cell survival that relates to the time course of myocardial stunning and differs transmurally in relation to ischemic stress, which induced the stunning. Understanding the genes up-regulated during myocardial stunning, including those not previously described in the heart, and developing strategies that activate this program may open new avenues for therapy in ischemic heart disease.

Indexed as

AnimalsApoptosisCell SurvivalDNA, ComplementaryFemaleGene Expression ProfilingIn Situ HybridizationMyocardial IschemiaMyocardiumReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSwineDNA, ComplementaryRNA, Messenger

Identifiers

PMID11481491
PMCPMC55421
OpenAlexW1983619570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.